When the time came for Stephen Hoffman to retire, rocking chairs and golf clubs weren’t in the picture. The 52-year-old former leader of malaria research efforts and vaccine development for the US Navy served for 21 years, long enough to retire with full benefits, according to Navy policy. Rather than find a condo in Florida, Hoffman joined Celera in the new position of senior vice president of immunotherapies.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.